Initial emergency department mechanical ventilation strategies for COVID-19 hypoxemic respiratory failure and ARDS.
Am J Emerg Med
; 38(10): 2194-2202, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: covidwho-634245
ABSTRACT
INTRODUCTION:
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging viral pathogen that causes the novel coronavirus disease of 2019 (COVID-19) and may result in hypoxemic respiratory failure necessitating invasive mechanical ventilation in the most severe cases.OBJECTIVE:
This narrative review provides evidence-based recommendations for the treatment of COVID-19 related respiratory failure requiring invasive mechanical ventilation.DISCUSSION:
In severe cases, COVID-19 leads to hypoxemic respiratory failure that may meet criteria for acute respiratory distress syndrome (ARDS). The mainstay of treatment for ARDS includes a lung protective ventilation strategy with low tidal volumes (4-8 mL/kg predicted body weight), adequate positive end-expiratory pressure (PEEP), and maintaining a plateau pressure of < 30 cm H2O. While further COVID-19 specific studies are needed, current management should focus on supportive care, preventing further lung injury from mechanical ventilation, and treating the underlying cause.CONCLUSIONS:
This review provides evidence-based recommendations for the treatment of COVID-19 related respiratory failure requiring invasive mechanical ventilation.Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Respiración Artificial
/
Insuficiencia Respiratoria
/
Lesión Pulmonar Inducida por Ventilación Mecánica
/
COVID-19
Tipo de estudio:
Estudio observacional
/
Estudio pronóstico
/
Revisiones
Tópicos:
Covid persistente
Límite:
Humanos
Idioma:
Inglés
Revista:
Am J Emerg Med
Año:
2020
Tipo del documento:
Artículo
País de afiliación:
J.ajem.2020.06.082
Similares
MEDLINE
...
LILACS
LIS